To Evaluate the Performance of Total 30 (Lehifilcon A) Contact Lenses in Patients Using Digital Devices for Greater Than 8 Hours Per Day 5 Days Per Week Based on Subjective Reported Data.
Performance of TOTAL30 (Lehfilcon A) Contact Lenses in Patients Using Digital Devices and 89814415
1 other identifier
interventional
35
1 country
1
Brief Summary
To evaluate the performance of Total 30® (lehfilcon A) contact lenses in patients using digital devices for greater than 8 hours per day 5 days per week based on subjective reported data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2024
CompletedFirst Posted
Study publicly available on registry
March 19, 2024
CompletedStudy Start
First participant enrolled
March 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMay 1, 2025
April 1, 2025
8 months
March 12, 2024
April 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Likert question about comfort satisfaction while wearing Total 30 contact lenses on a typical day (> 13 hours of daily wear) after 1 month of wear and heavy digital device usage (>8 hours daily wear).
Likert Questionaire: Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree
1 month
Secondary Outcomes (3)
Likert responses to insertion comfort and overall vision, and heavy digital device use on a typical day after 1 month of wear.
1 month
Results of subjective ratings of patients using Total 30 lenses and heavy digital device usage with VAS diary questionnaire.
1 month
Report on total daily wear time and digital device usage.
1 month
Study Arms (1)
Digital Device uses for 8 hours per day
OTHERObservational responses from patients using digital devices for 8 hours per day will be given a monthly Total 30 Contact lens.
Interventions
Patients will be give a contact lens for 1 month
Eligibility Criteria
You may qualify if:
- Adult patients aged 18-40 of any sex and any race.
- Reports habitually using digital device usage (phone, Ipad, computer, social media, video streaming) for 8 hours or more per day 5 days per week with plans to continue the habit throughout the study.
- Wearing contact lenses for at least 13 hours daily 5 days per week.
- Spherical refractive error between -11.00 D and +6.00D with \< -0.75 D of astigmatism.
- Willing to comply with the protocol instructions.
- Has read (or has had read to), understood, and signed an Informed Consent.
- Willing to not use any artificial tears, rewetting drops or dry eye treatments during the study.
You may not qualify if:
- Active ocular infection or ocular inflammatory disease.
- Presbyopic or pre-presbyopic that have a measured add power for reading.
- Current Total 30 contact lens wearer.
- Anterior basement membrane dystrophy or history of recurrent erosion syndrome or topographical abnormalities that might indicate ectasia or other corneal degenerative conditions.
- Current or previous diagnosis of dry eye disease; currently using a dry eye treatment including but not limited to artificial tears, rewetting drops or prescription treatments.
- History of severe / serious ocular pathology or other medical conditions that could result in an inability to safely complete the study.
- Participation by the patient in any other investigational study within the past 30 days.
- Unlikely to comply with protocol instructions for any reason (confusion, substance abuse, etc.). The Principal Investigator or the Medical Monitor reserves the right to declare a patient ineligible based on medical evidence that indicates the patient is unsuitable for the study.
- Inability to utilize Clear Care Cleaning solution.
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tauber Eye Centerlead
- Alcon Researchcollaborator
Study Sites (1)
Tauber Eye Center
Kansas City, Missouri, 64111, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Crystal Remington OD, FAAO
Study Record Dates
First Submitted
March 12, 2024
First Posted
March 19, 2024
Study Start
March 31, 2024
Primary Completion
November 11, 2024
Study Completion
December 1, 2024
Last Updated
May 1, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared.